S tem cells possess the capacity to self-renew (a process of duplication without loss of developmental potential), which enables maintenance of the initial stem cell pool, and the ability to differentiate into distinct lineages. 1, 2 Stem cell renewal and differentiation requires selective activation or silencing of specific transcription programs. This is achieved by an intensive cross talk between transcription factor networks and epigenetic modulators regulating the chromatin structure of the packaged eukaryotic genome. Epigenetics is defined as the sum of processes that cause heritable and reversible changes of gene expression patterns that do not involve changes of primary DNA sequences. 3, 4 Central to epigenetic control is the modification of chromatin, a complex assembly of DNA, RNA, histone, and nonhistone proteins. Two types of chromatin have been characterized: euchromatin and heterochromatin. Heterochromatin is found in chromosomal regions that contain relatively few genes, such as centromeres and telomeres (constitutive heterochromatin), or regions where genes are silenced (facultative heterochromatin). Compared with heterochromatin, euchromatin is more decondensed and transcriptionally active. 5 Signals that activate stem cells such as cardiac progenitor cells are transmitted to chromatin, which leads to genomewide redistribution of epigenetic modifications and hence alteration of chromatin structure and gene expression. Epigenetic modifications establish the memory of active and silent gene states and contribute to determination of stem cell fates. 6, 7 Well-studied epigenetic modifications comprise DNA methylation, posttranslational histone modifications, and ATP-dependent chromatin remodeling.
Setting the Stage: Different Types of Chromatin Modifications and Modes of Action

DNA Methylation
The first well-characterized epigenetic modification identified in vertebrates was methylation of the 5 position of the cytosine pyrimidine ring within cytosine-guanine dinucleotide (CpG) dinucleotides, resulting in 5-methylcytosine (5mC). This reaction is catalyzed by a family of DNA methyltransferases (DNMTs). DNMT1 appears to be required for maintenance of CpG methylation, whereas DNMT3a and DNMT3b have been shown to be required for de novo CpG methylation. 8 5mC can be further oxidized to produce 5Јhydroxymethylcytosine (5hmC) by TET (ten-eleven translocation) proteins, which belong to the family of Fe(II)/2oxoglutarate-dependent dioxygenases. 9 Regulation of the transition of 5mC to 5hmC is critical for maintenance of DNA methylation levels in the mammalian genome. 9 DNA methylation is reversible either by passive demethylation via DNA replication or through active demethylation by mechanisms that are involved in DNA repair. 10 In mammals, activation-induced (cytosine) deaminase (AID)-mediated 5mC deamination leads to the generation of a T:G mismatch, which in turn can be efficiently repaired by thymine-DNA glycosylase (TDG) and methyl-CpG-binding domain protein 4 (MBD4), thus eventually resulting in active DNA demethylation. [11] [12] [13] Alternatively, 5mC might first be oxidized to produce 5hmC and subsequently demethylated by the passive DNA demethylation pathway or serve as an intermediate for active DNA demethylation by the AID/TDG pathway 14, 15 ( Figure 1A) . The general view of the function of DNA methylation in gene regulation is that 5mC is associated with gene silencing, whereas 5hmC is associated with gene activation of permissive genes. 16 -20 
Posttranslational Modifications of Histones
Histones can be subjected to a variety of posttranslational modifications, such as lysine acetylation, lysine and arginine methylation/citrullination, serine and threonine phosphorylation, lysine ubiquitylation and sumoylation, and lysine ADPribosylation. 21, 22 Compared with DNA methylation, histone modifications display more diversity and complexity, and their regulation is more dynamic. The most extensively studied histone modifications are acetylation/deacetylation and methylation/demethylation, which are mediated by histone acetyltransferases/histone deacetylases, and histone methyltransferases/histone demethylases, respectively 23, 24 ( Figure 1B ).
ATP-Dependent Chromatin Remodeling
ATP-dependent chromatin remodeling complexes use energy from ATP hydrolysis to move, destabilize, evict, or reassemble nucleosomes, which results in alteration of chromatin structure and DNA accessibility, thereby providing another means for the regulation of gene expression. In mammalian cells, approximately 30 genes have been identified to encode ATP-dependent chromatin remodeling factors. These genes can be grouped into 4 different families: SWI/SNF (switching defective/sucrose nonfermenting), ISWI (imitation switch), CHD (chromodomain, helicase, DNA binding), and INO80 (inositol requiring 80). 25
The Epigenetic Code and Epigenetic Language Hypotheses
Currently, 2 overlapping models have been proposed to explain the mechanism by which epigenetic modifications affect gene expression: the direct model and the readermediated model. 26 The direct model assumes that epigenetic 27, 28 Similarly, poly ADPribosylation of histones by PARP-1 (poly ADP-ribosylation polymerase 1) leads to poly ADP-ribosylation-dependent stripping of histones from chromatin, thereby favoring an open chromatin structure and transcriptional activation. 29, 30 Direct changes of chromatin structure can also be achieved by ATP-dependent chromatin remodeling. Nucleosome eviction, destabilization, and incorporation of different histone variants by ATP-dependent chromatin remodeling complexes reconfigure chromatin structures, which results in distinct states of accessibility for regulatory proteins to DNA. 31 The readermediated model suggests that epigenetic modifications can be translated into downstream events via protein modules termed readers, which modulate transcription by recruitment or stabilization of distinct chromatin components. 26, 32 Many readers have been identified and characterized. Mbd2 (methyl-CpG-binding domain protein 2) and MeCP2 (methyl-CpG-binding protein 2) are "methyl-readers" and as such bind to methylated CpG, simultaneously recruiting transcrip-tional corepressors to specific promoters to silence target genes. [33] [34] [35] Chromatin factors that contain bromodomains, which function as "acetyl-readers," can recognize acetylated lysine residues on different histones and translate the epigenetic acetylation mark to transcriptional activation or silencing. 36 -38 Similarly, the tandem PHD (plant homeo domain) motifs in the histone-binding protein DPF3b (D4, zinc and double PHD fingers, family 3b) can also act as an acetylreader module. 39 The 14-3-3 domain acts as a "phosphoreader" and binds to phosphorylated serine 10 of H3 during chromosome condensation. 40 Another example is the DNA damage checkpoint protein 1 (MDC1), which contains tandem BRCT (BRCA1 C terminus) domains that recognize phosphorylated serine 139 in ␥H2AX during recognition of DNA damage. 41 A more complicated scenario arises from the finding that different histone methyl-readers, such as chromo (chromodomain), PHD, Tudor, proline-tryptophantryptophan-proline (PWWP), MBT (malignant brain tumor), WD40 (tryptophan-aspartic acid [WD] dipeptide 40), and AKR (ankyrin repeat) domains, can all recognize the same methylation modification. 26, 42, 43 Moreover, some of these domains additionally recognize and distinguish between non- methylated, monomethylated, dimethylated, and trimethylated lysine residues or between different types of symmetrical or asymmetrical methylated arginine residues, which demonstrates that epigenetic regulation is intricately finetuned. 44 -46 The distinct epigenetic modifications mediated by the plethora of writers (referring to enzymes that mediate modifications on chromatin), readers, and erasers (referring to enzymes that remove modifications from chromatin) are assumed to represent an "epigenetic code," which determines chromatin-mediated gene expression 47 ( Figures 1A and 1B ). Yet, it becomes increasingly clear that it also matters by which order and mechanism modifications are added and removed. Hence, epigenetic regulation resembles more a "language" with a syntax rather than a simple code. 6, 48 A striking example is given by the finding that phosphorylation of serine 10 on histone H3 is required for Gcn5 (general control nonrepressible 5)-mediated acetylation at lysine 14 on the same histone. 49, 50 Such a cross talk among epigenetic modifications also occurs between different histones. For example, monoubiquitylation of H2BK120 is required for H3K4 methylation. 51 Epigenetic modifications also repress each other. Methylation of H3R2 inhibits H3K4 methylation and represses gene activation 52 ( Figure 1C ). Notably, epigenetic modifiers can assemble into multisubunit complexes that contain different writers, readers, and erasers that act simultaneously to generate a specific chromatin state, which suggests that a comprehensive evaluation of the syntax of the epigenetic language will be key to the understanding of gene regulation. 6, 48 
Epigenetic Regulation in Embryonic Stem Cells and Induced Pluripotent Stem Cells Epigenetic Remodeling in Embryonic Stem Cells
Embryonic stem (ES) cells are derived from the inner cell mass of the preimplantation embryo and are characterized by the capability for self-renewal and differentiation into all principal cell types of the embryo proper. At the molecular level, ES cells are defined by expression of the transcription factors Oct4, Sox2, and Nanog, which belong to the family of pluripotent genes required for self-renewal. 53 ES cells have been widely used as a model to decipher the epigenetic mechanisms of cell fate determination and cell homeostasis. Initial observations made by electron microcopy revealed that the chromatin in ES cells is more homogeneously spread and loosely packaged than chromatin of differentiated cells, in which it is more compacted and contains distinct condensed chromatin blocks. 54 Biochemical studies of the chromatin structure by nuclease digestion indicated reduced condensation of the chromatin structure in undifferentiated ES cells. Consistently, Western blot analyses revealed that the heterochromatic marker H3K9me2 is enriched in differentiated cells. 55 Along this line, genome-wide chromatin immunoprecipitation (ChIP) on chip or chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) analyses revealed a higher abundance of heterochromatic H3K9me2 in differentiated ES cells and a decrease of euchromatic H3K9ac after ES cell differentiation. 56, 57 It has been shown that in undifferentiated ES cells, pluripotent genes are in a euchromatic, transcriptionally active state, whereas genes associated with differentiation are heterochromatic and transcriptionally silent. Reconfiguration of chromatin structure occurs during ES cell differentiation whereby euchromatic regions, in particular those associated with pluripotency genes, are transformed to heterochromatin, and conversely, chromatin regions associated with differentiation genes become euchromatic. Therefore, chromatin factors that confer euchromatin and heterochromatin transitions appear to play an important role in ES cell self-renewal and cell fate determination 58, 59 (Figure 2A ).
Another striking epigenetic feature of ES cells, which was revealed by genome-wide chromatin immunoprecipitation on chip analyses and chromatin immunoprecipitation followed by deep sequencing, is that they contain bivalent chromatin domains. Bernstein and colleagues 60 showed that key regulatory regions of many critical transcription factors involved in lineage commitment are associated with both the active chromatin modification H4K3me3 and the silent chromatin modification H3K27me3. 5hmC has also been identified recently as an active epigenetic marker for bivalent chromatin. 19 The relative amount of these modifications can effectively discriminate the state of gene expression at individual promoters, whereas the global amount of bivalent markers across the whole genome does not change significantly. 61 Bivalent domains are resolved on ES cell commitment to a particular lineage when the silencing H3K27me3 mark is removed and the activating H3K4me3 is retained. 62 This process coincides with association of active RNA polymerase II (Pol II) to distinct regions within bivalent domains, which leads to activation of poised genes and commitment to a specific lineage. In contrast, bivalent domains of other genes required for the commitment of ES cells to different lineages remain silenced, containing H3K27me3, H3K9me3, and 5mC DNA methylation, which confers a stable chromatin state [63] [64] [65] ( Figure 2B ). Bivalent chromatin domains in ES cells constitute a "metastable" state that retains the ability of critical genes to become activated in response to specific cues. Changes in bivalent chromatin domains define and preserve specific cell identities but also determine the ability of cells to acquire a different state if they remain unresolved after differentiation. 58 Indeed, chromatin factors that establish, maintain, or resolve bivalent chromatin structures have been shown to play important roles in control of ES cell differentiation and commitment of cardiovascular progenitor cells.
DNA Methylation and Differentiation of ES Cells
The epigenetic memory of ES cells, which contributes to the incessant potential of self-renewal and differentiation, must be faithfully transmitted during each cellular division. It is believed that the cellular memory is mainly inherited by DNA methylation. In undifferentiated ES cells, chromatin factors that write, read, and erase DNA methylation are highly expressed, and high global levels of DNA methylation are detected. 20, 66 Upon ES cell differentiation and lineage commitment, genome-wide redistribution of DNA methylation occurs, affecting differentiation and maintenance of cell-type identities. 4,16 -18 Alterations of DNA methylation occur mostly in the promoter regions of stem cell-specific genes, including those that encode pluripotency transcription factors. 4 Interestingly, DNA methyltransferases do not appear to be required for ES cell self-renewal but are necessary for ES cell differentiation and lineage commitment. During differentiation, it is necessary to stably silence genes required for pluripotency and genes required for differentiation into "unwanted" lineages. 63, 67 Recently, it was demonstrated that a shift in the balance between hydroxymethylation and methylation of DNA across the genome is inextricably linked with a change of the equilibrium between pluripotency and lineage commitment. 16, 19 The balance between pluripotency and lineage commitment depends on the lasting activity of TET and TDG. Both proteins counteract aberrant de novo DNA methylation and therefore contribute to the maintenance of active and bivalent chromatin regions. 16 -19,68 
Histone Modifications and ES Cell Regulation
Histone-modifying enzymes that mediate transitions between euchromatin and heterochromatin states or that resolve bivalent chromatin structures have a profound impact on ES cell fate determination. Two of the most extensively studied histone modifications are H3K4 and H3K27 methylation. Regulation of H3K4 methylation by histone methyltransferases and demethylases is particularly intriguing because this modification is involved both in changes of global chromatin structure and in resolving bivalent chromatin domains during ES cell differentiation. H3K4 methylation is catalyzed by mammalian trithorax group (TrxG) MLL/Set1 (myeloid/lymphoid or mixed-lineage leukemia) complexes (hereafter MLL complexes). MLL complexes keep genes in an active state during ES cell fate determination. 69, 70 Several MLL complexes have been identified in ES cells, which contain different catalytic subunits (hSet1, MLL1, MLL2, MLL3, or MLL5) and several integral core subunits. 71 Depletion of different catalytic subunits leads only to minor alterations of H3K4 methylation levels, whereas depletion of several core subunits of different complexes reduces H3K4 methylation, which suggests a redundant function of different H3K4 methyltransferases. 71, 72 The function of MLL complexes in ES cells differs depending on whether they affect global H3K4 methylation or H3K4 methylation within bivalent chromatic regions. Loss of MLL1 and MLL2 does not impair global H3K4 methylation and does not regulate ES cell self-renewal but contributes to the coordination and timing of early differentiation. 73, 74 Similarly, depletion of Dpy-30, a common subunit of all MLL complexes, leads to a mild reduction of H3K4me3 and distorts ES cell differentiation but not self-renewal by decreasing H3K4me3 within bivalent domains. 75 On the other hand, depletion of Wdr5 (WD repeat-containing protein 5), a reader of H3K4 methylation and core subunit of different MLL complexes, results in dramatic genome-wide reduction of H3K4 methylation and defects in ES cell self-renewal. 72, 76 At present, it appears that MLL complexes that regulate global H3K4me3 levels affect ES cell self-renewal, whereas those that only regulate bivalent chromatin regions affect differentiation. However, additional studies focusing on the mechanisms by which MLL complexes target bivalent and nonbivalent chromatin regions are necessary to corroborate this hypothesis and deepen our insight into the role of different MLL complexes in ES cell regulation. Notably, H3K4 methylation is also dynamically controlled by histone demethylases, some of which have been shown to be involved in ES cell regulation. H3K4 demethylase Kdm5b (lysine-specific demethylase 5b) regulates genome-wide H3K4 methylation and appears to be required for ES cell self-renewal and blockage of terminal differentiation. 77, 78 LSD1 (lysine-specific demethylase 1) has been shown to demethylate H3K4me2 in bivalent chromatin domains in murine and human ES cells. Its depletion induces defects in ES cell differentiation and progressive loss of DNA methylation, thereby linking histone H3K4 demethylation to DNA methylation in the control of ES cell fates. 79, 80 H3K27 methylation is catalyzed by PRC2 (Polycomb repressive complex 2), which belongs to the PcG (Polycomb group) protein family and is involved in permanent silencing of genes or in keeping "poised" genes silent before gene activation during ES cell differentiation. 81 Genome-wide analyses revealed that several PRC2 proteins preferentially bind to silent genes involved in developmental regulation. Interestingly, PRC2 proteins are not essential for ES cell self-renewal but play an important role in differentiation, because ES cells depleted of the PRC2 protein Suz12 (suppressor of zeste 12 homolog), Ezh1/Ezh2 (enhancer of zeste homolog 1/2), and Jarid2 (Jumonji, AT-rich interactive domain 2) can still be propagated in an undifferentiated state in vitro. [82] [83] [84] Similarly, removal of H3K27me3 by the histone demethylase Jmjd3 (Jumonji domain-containing 3) and UTX (ubiquitously transcribed tetratricopeptide repeat, X chromosome) is only required for ES cell differentiation but not self-renewal, which underscores the dynamic regulation of H3K27 methylation in controlling ES cell differentiation. 62, 85 Other histone modifications control ES cell fates mainly by regulating the transition between euchromatin and heterochromatin. Regulation of H3K9 methylation by multiple histone H3K9 methyltransferases and demethylases has been implicated in the control of ES cell self-renewal. The histone H3K9 methyltransferase SETDB1 (SET domain, bifurcated 1) is required for maintenance of overall H3K9 methylation and ES cell self-renewal. 65, 86 The H3K9 demethylases Jmjd1a and Jmjd2c are also involved in self-renewal, because their depletion leads to ES cell differentiation accompanied by reduced expression of pluripotent genes and induction of lineage marker genes. 87 Similarly, GCN5, which regulates the global amount of H3K9 acetylation, a histone modification enriched in undifferentiated ES cells, has been shown to be involved in the regulation of ES cell self-renewal. 88 Additionally, arginine methylation is among the earliest markers of inner cell mass development. Ablation of arginine methyltransferases such as CARM1 (coactivator-associated arginine methyltransferase 1) and PRMT5 (protein arginine methyltransferase 5) decreases arginine methylation and impairs ES cell self-renewal. 89 -91 It is tempting to postulate that histone modifiers, which regulate global and bivalent chromatin transitions, affect transcription of both pluripotency and differentiation genes, but histone modifiers that only resolve bivalent chromatin regions, such as PRC2, specifically regulate ES cell differentiation.
ATP-Dependent Chromatin Remodeling and ES Cell Regulation
FRAP (fluorescence recovery after photobleaching) experiments revealed higher turnover rates of histones of ES cells than of committed cells, which suggests that nucleosome stability and composition change during differentiation. 55 The enhanced turnover rate of histones is due in part to the action of ATP-dependent chromatin remodeling complexes that control ES cell identity via different mechanisms. One of these factors is a specialized SWI/SNF complex called esBAF (Brahma-associated factor). The catalytic ATPase subunit of esBAF known as Brg1 (Brahma-related gene 1) is downregulated on differentiation, and depletion of Brg1 in ES cells induces aberrant morphology, reduced proliferation, and impaired differentiation, which pinpoints its role in both self-renewal and differentiation. 92 Other members of the SWI/SNF family involved in ES cell regulation are the 2 related proteins BAF250A and BAF250B, which have distinct functions, which suggests that changes in the composition of the SWI/SNF complex allows specific targeting of genes required for self-renewal or differentiation. 93, 94 Other important chromatin remodeling proteins are CHD1 and CHD3/CHD4. CHD1 associates with active euchromatin and RNA polymerase II, controls the transition between euchromatin and heterochromatin during ES cell differentiation, and is critical for maintaining pluripotency. 95 CHD3 and CHD4 are key components of the nucleosome remodeling and deacetylation complex (NuRD), which is instrumental for normal ES cell differentiation. 96 Bromodomain PHD finger transcription factor (BPTF), a core subunit of NURF (nucleo-some remodeling factor), which itself belongs to the ISWI family, is also required for ES cell differentiation both in vitro and in vivo. 97 Finally, the Tip60-p400 complex, a member of the INO80 family, has been found to maintain ES cell identity by regulating pluripotent gene expression via its intrinsic chromatin remodeling and histone acetyltransferase activities. 98 Table 1 lists selected epigenetic modifiers with their functions in ES cells.
Epigenetic Regulation in Induced Pluripotent Stem Cells
Somatic cells can be reprogrammed to a pluripotent state by overexpression of Oct4, Sox2, Klf4/Nanog, and c-Myc/ LIN28. 99 -101 Reprogramming is accompanied by massive reconfiguration of chromatin structure, including DNA demethylation, changes in histone modifications, and repositioning of nucleosomes, which indicates that epigenetic barriers are overcome during this process. 102, 103 The efficiency of induced pluripotent stem (iPS) cell generation increases when small molecules that facilitate formation of open chromatin structures are used. In particular, the DNMT inhibitor 5-aza-cytidine, the histone deacetylase inhibitor valproic acid, and the histone methyltransferase G9a inhibitor BIX-01294 dramatically enhance the efficiency of iPS generation, 102, 104, 105 which indicates that reopening of chromatin in somatic cells is a prerequisite for activation of the regulatory networks required for self-renewal and pluripotency. Along this line, the chromatin remodeling factors Brg1 and BAF155, 2 subunits of the SWI/SNF complex, were recently identified in an unbiased screen for factors that facilitate iPS reprogramming. Coexpression of Brg1 and BAF155 with iPS factors results in a more than 10-fold increase in the efficiency of iPS cell generation from mouse embryonic fibroblasts and can replace c-Myc for reprogramming. 103 Further studies revealed that depletion of CHD1 inhibits iPS reprogramming. 95 Although iPS cells are similar to ES cells, subtle differences in epigenetic modifications between these 2 pluripotent cell types exist. Stadtfeld et al 106 demonstrated that the epigenetic landscape and gene expression signatures of ES and iPS cells are highly similar but not completely identical. Both cells types differ substantially in the regulation of an imprinted gene cluster on mouse chromosome 12qF1. Most iPS clones show aberrant epigenetic silencing of the Dlk1-Dio3 locus located within this cluster. Silencing of the Dlk1-Dio3 locus in iPS cells prevents development of all-iPS mice generated by tetraploid complementation and only permits formation of relatively poor chimeras. 106 Interestingly, treatment of iPS cells carrying a silenced Dlk1-Dio3 locus with DNMT and histone deacetylase inhibitors reactivated the locus, thereby allowing formation of all-iPS mice. 106, 107 Moreover, iPS cells tend to differentiate preferentially into the somatic cell type from which they were derived, which suggests that some epigenetic memory of the starting cell population is retained in early-passage iPS cells. At present, it is unclear whether this is due to incomplete reprogramming or an unavoidable byproduct of the reprogramming procedure itself. 57,107-109 It will be pivotal to elucidate the mechanisms that maintain even faint epigenetic memories and improve existing technologies to allow full epigenetic reprogramming of iPS cells. We do not know whether remaining epigenetic marks might compromise the use of iPS cell-derived cardiac cells, but it is easy to image that such regulatory remnants might favor nonphysiological responses under certain conditions. Rigorous quality testing of iPS cells and tissue-specific derivatives, which needs to include the epigenetic landscape, is mandatory to unfold the potential of ES and iPS cells for potential cell replacement therapies in the heart. It is particularly attractive to generate cardiac progenitor cells rather than differentiated cardiomyocytes, because the former cell population might undergo limited expansion in vivo, which would reduce the need for transplantation of large cell numbers. Recently, human ES cell-derived cardiac progenitors have been shown to generate cardiomyocytes, endothelial cells, and smooth muscle cells in vitro and after transplantation into nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice in vivo. 110 Unfortunately, the "correct" epigenetic landscape of cardiac progenitor cells is unknown, which makes a quality assessment difficult. Additional challenges can be foreseen for patient-specific iPS cells. Although in principle, patientspecific iPS cells represent a suitable source for generation of large numbers of different cardiac cell types, including multipotent cardiac progenitors, a thorough quality control (including the epigenome) for each individual iPS clone will generate major logistical problems. Generation of a library of immune-compatible iPS or ES cells with defined epigenetic properties would circumvent such hassles but would still allow avoidance of posttransplant immunosuppression. [111] [112] [113] 
Epigenetic Regulation of Adult Stem Cells
Adult stem cells are responsible for maintaining the natural homeostasis of several adult tissues. They supply a continuous replacement pool of differentiated cells and respond to signals that induce tissue repair after injury. 114 Adult stem cells can divide symmetrically to expand individual cell populations at different stages of differentiation. Asymmetrical cell divisions generate different types of progeny, thereby maintaining the stem cell pool and generating more mature cell types, such as transit-amplifying cells. 115 Emerging evidence indicates that epigenetic modifications play an important role in the control of adult stem cell self-renewal and differentiation. Similar to ES cells, adult stem cells contain bivalent chromatin domains. Genome-wide comparisons between ES cells, neural stem cells (NSCs), and mouse embryonic fibroblasts indicate that genes involved in neurogenesis are bivalent in embryonic and neural stem cells but monovalent in mouse embryonic fibroblasts. 61 During differentiation of hematopoietic stem cells (HSCs) to erythrocyte precursors, the majority of genes associated with a bivalent chromatin state in undifferentiated HSCs remain silent and lose the H3K4me3 mark after differentiation. In contrast, genes without the H3K27me3 mark become activated after differentiation and are associated with increased levels of active RNA polymerase II. These findings suggest that chromatin modifications already present in the undifferentiated state affect gene expression during differentiation. Indeed, localization of bivalent chromatin domains correlates with expression of crucial genes required for terminal differentiation. 116 Therefore, it is not surprising that many chromatin factors that have been identified to regulate ES cell fates play similar roles in adult stem cell regulation.
DNA Methylation and Regulation of Adult Stem Cells
DNA methylation is an essential epigenetic mechanism that protects adult stem cells from premature activation of differentiation. It is required for both progenitor maintenance and lineage commitment. For example, ablation of DNMT1 in epidermal progenitor cells and MBD1 in NSCs impairs progenitor/stem cell differentiation and eventually results in loss of the respective tissue. [117] [118] [119] DNMT1-deficient HSCs, which are not capable of suppressing key myeloerythroid regulators, differentiate into myeloerythroid but not lymphoid progenitors, which indicates that the self-renewal program of HSCs requires constitutive maintenance of DNA methylation above a critical threshold. 120, 121 In agreement with this hypothesis, DNMT3a and DNMT3b are essential for HSC self-renewal but not for differentiation. 122
Histone Modifications and Regulation of Adult Stem Cells
Because of the finding that bivalent chromatin is an important feature of adult stem cells, regulation of adult stem cells by histone methyltransferases and demethylases has attracted much attention. MLL complexes control H3K4me3 levels of genes in adult stem cells primarily associated with developmental processes. In postnatal NSCs, MLL1 is required to activate key silenced bivalent loci such as Dlx2 (distal-less homeobox 2). This transition induces neurogenesis but not gliogenesis, which suggests a role for MLL1-mediated H3K4 methylation in NSC differentiation and lineage specification. 123 Consistently, inhibition of the H3K4 demethylase LSD1 also leads to a dramatic reduction of NSC proliferation. 124 In contrast, depletion of MLL1 and MLL5 in HSCs primarily impairs stem cell integrity and self-renewal but not lineage specification, 125, 126 which suggests that MLL complexes play different roles in HSCs and NSCs. Loss of Ezh2, the central enzyme of PRC2 complex, yields reduced H3K27me3 levels and alters lineage commitment and cell specification in HSCs and NSCs. [127] [128] [129] In addition, Kdm2b, a histone H3K36 monodemethylase/di-demethylase, forms a complex with Polycomb group proteins to promote expansion of HSCs and to prevent exhaustion of their long-term repopulating potential, 130, 131 which suggests a cooperative function of histone methyltransferase and demethylase activities in the regulation of HSC fates. Furthermore, the histone H4K20 methyltransferase Suv4 -20h1/h2 is required for maintenance of the lymphoid progenitor cell pool. 132 Depletion of Sirt1 (Sirtuin 1), a class III histone deacetylase, leads to impaired self-renewal of HSCs and defects in specification of NSCs to the neuronal lineage. 133, 134 
ATP-Dependent Chromatin Remodeling and Regulation of Adult Stem Cells
SWI/SNF-dependent chromatin remodeling is not only involved in the regulation of ES cell fates but also plays a major role in the determination of adult stem cell fates. Using a proteomics approach, Lessard et al 135 demonstrated that determination of the fate of NSCs is accompanied by a switch in the subunit composition of SWI/SNF complexes. BAF45a and BAF53a, 2 subunits of the SWI/SNF complex, were detected in proliferating NSCs and progenitor cells but were replaced by their homologues, BAF45b and BAF45c or BAF53b, when neural progenitors exited the cell cycle and differentiated into neurons. Intriguingly, inhibition of this switch prevented neuronal differentiation. 135 The importance of ATP-dependent chromatin remodeling in the regulation of adult stem cells has also been demonstrated by conditional inactivation of the CHD4/NuRD complex in murine HSCs. These mice display an early increase in HSC numbers, followed by a late depletion of the HSC pool. Most likely this is due to loss of quiescent HSCs and increased apoptosis of cycling CHD4-deficient HSCs. 136 Table 2 lists selected epigenetic modifiers involved in adult stem cell/progenitor cell regulation.
Numerous Roads to Stemness: Major Differences in Chromatin-Mediated Regulation of Adult Stem Cells and ES Cells
Although bivalent chromatin domains are found in both adult stem cells and ES cells, and similar sets of chromatin modifiers are involved in the regulation of the fates of adult stem cells and ES cells, no common molecular chromatin signature exists in different stem cell types, which suggests that different mechanisms are at work to maintain stemness. [137] [138] [139] In fact, DNA methyltransferases play different roles in controlling the fates of ES cells and HSCs. DNMT1and DNMT3a/3b-deficient ES cells maintain replication potential but are unable to differentiate, whereas DNMT1-or DNMT3a/3b-deficient HSCs lose self-renewal capability but maintain their differentiation potential. 63, 67, 122 Similarly, the histone H3K27 methyltransferase Ezh2 regulates differentiation of ES cells, HSCs, and NSCs but controls self-renewal and suppresses nonmuscle lineage commitment in muscle stem cells. 140 In addition, the chromatin structure of adult skeletal muscle stem cells differs significantly from that of ES cells. Muscle stem cells contain highly condensed heterochromatin that can be readily observed in electron micrographs, whereas nuclei of ES cells show much more euchromatin. 54, 141 Recently, we also identified several distinct epigenetic modifications that define the chromatin of muscle stem cells (Y.Z. et al, unpublished data, 2011). It will be interesting to analyze whether other types of adult stem cells such as cardiovascular stem cells show similar features and are regulated by similar or different mechanisms to control self-renewal and differentiation.
Epigenetic Regulation of Cardiac Progenitor Cell Differentiation During Heart Development
The existence of adult cardiac stem cells is still a matter of a fierce debate, although several markers have been proposed to identify cardiac stem cells. 142, 143 In contrast, the epigenetic mechanisms underlying cardiac progenitor cell differentiation during heart development are well studied. Cardiac lineage commitment during heart development requires intimate interaction between cardiac-specific transcription networks and epigenetic modifiers. Several master cardiac transcription factors, such as Nkx2.5, Isl-1, Mef2c, GATA-4, and Tbx-5, have been shown to form complexes with epigenetic modifiers. These interactions result in specific epigenetic modifications of promoters of cardiac specific genes, thereby regulating gene expression during cardiac lineage specification. 144, 145 The involvement of epigenetic mechanisms in cardiac differentiation has been revealed by mutations of several chromatin modifiers, such as ATP-dependent chromatin remodeling complex CHD7, 146 WSTF (Williams syndrome transcription factor), 147 and histone H3K36 methyltransferase Wolf-Hirschhorn syndrome candidate 1 (WHSC1). 148 All of these factors are also involved in the pathogenesis of human heart diseases. 149 Genetic studies in mice uncovered the crucial role of chromatin remodeling and other epigenetic mechanisms in cardiac differentiation. Baf60c and Brg1, 2 well-studied SWI/SNF components, coregulate cardiacspecific gene expression by recruiting BAF chromatin remod-eling complexes to heart-specific enhancers, thereby potentiating activation of target genes. 150, 151 Consistent with this hypothesis, coexpression of Baf60c with the transcription factors Gata4, Nkx2.5, and Tbx-5 induces cardiac differentiation in the mesoderm of mouse embryos. 152 The role of histone deacetylases, which control the degree of histone acetylation, in the regulation of transcriptional processes in the heart and as crucial regulators of cardiac differentiation and development is well known. Interested readers are referred to one of the several contemporary reviews for more comprehensive discussion of the subject. 145, 153, 154 Histone deacetylases and acetyltransferases might not only affect the degree of histone acetylation but also control gene expression by other mechanisms. The histone acetyltransferase p300 is known to both acetylate histones within cardiac-specific gene promoters and to increase DNA binding activity of several cardiac transcription factors. [155] [156] [157] Increasing evidence also suggests an involvement of histone methyltransferases in cardiac differentiation. For example, the H3K36 methyltransferase WHSC1 has been demonstrated to interact with Nkx2.5 to repress transcription of Nkx2.5-targeted genes in embryonic hearts, which is essential for normal heart development. 148 Similarly, Smyd1 (SET, MYND domain-containing 1), an H3K4 methyltransferase that acts downstream of the transcription factor Mef2c, is essential for cardiac differentiation. Smyd1-deficient mice die during embryonic development because of arrest of cardiomyocyte maturation. 158, 159 Jarid2, a subunit of the PRC2 complex, targets the H3K9 methyltransferases G9a and Glp to the cyclin D1 promoter and silences its expression during early heart development. 160 More information about the role of individual epigenetic modifiers for cardiac differentiation can be found elsewhere. 145, 154 Although many epigenetic modifiers have been identified to control cardiac differentiation, little is known about the chromatin structure within the cardiac progenitor cells, mostly because of technical restrictions caused by the limited amount of cells that can be isolated from developing embryos. Nevertheless, one might speculate that bivalent chromatin structures also exist in cardiac progenitor cells. Indeed, screening of promoters of some key genes instrumental in the direction of cell fate choices of early endoderm to different endodermal lineages revealed that such genes harbor a bivalent chromatin structure and are poised to become activated during liver and pancreas development. Intriguingly, the bivalent chromatin structures identified in these genes were atypical compared with ES cells, lacking H3K4me3 and containing H3K9acK14ac and H3K27me3. 161 It will be highly interesting to determine whether cardiac progenitor cells maintain similar bivalent chromatin structures in master regulatory genes of early heart development.
Conclusions and Perspectives
Stem cell/progenitor cell maintenance and differentiation involve cooperative interactions between transcription networks and epigenetic modifications. In this review, we have highlighted the epigenetic mechanisms that regulate fate determination of different types of stem/progenitor cells. Intrinsic reversibility and mutual dependence of different epigenetic mechanisms appear to be beneficial for stem cells to maintain their homeostasis. The inherent cross talk of different epigenetic mechanisms and mutually reinforcing nature of the epigenetic processes involved appear to ensure long-term cellular memory. It appears likely that epigenetic alterations are induced by both environmental cues and endogenous factors. Increasing evidence also suggests that specific stimuli trigger epigenetic changes. A comprehensive understanding of the regulatory network composed of epigenetic mechanisms and exogenous or endogenous signals will guide our understanding of the biology of stem cells and holds great potential for regenerative medicine.
Epigenetic studies in ES cells have revealed some of the basic mechanisms that control self-renewal and differentiation of stem cells. However, the detection of additional epigenetic modifications such as 5hmC and H3K56ac indicates that we are currently only seeing the tip of the iceberg and that there is much more to come. 9, 20, 162 A new layer of complexity also arises by the emergence of noncoding RNAs (ncRNAs), which have been shown to serve as direct epigenetic modifiers. 163, 164 Although it seems likely that additional modifications and epigenetic circuits will be unraveled, which will further improve our understanding of the complex machinery that controls stem cells, the real challenge might lay in the assessment of the relative impact of multiple distinct but interacting epigenetic processes to gain a more holistic view.
Profiling of epigenetic modifications on a genome-wide scale requires large, relatively homogeneous populations of cells. Such populations might be purified by fluorescence-activated cell sorting with specific antibodies that clearly define the state of a particular stem cell or by transgenic mouse reporter lines in which specific classes of progenitors/stem cells are labeled. On the other hand, more sophisticated genetic tools are now available that allow refined cell tracing and identification. The combined use of such genetic techniques together with the increasing power of genome-wide epigenetic profiling approaches raises hopes that it might become possible to read the epigenetic language that determines cardiac stem and progenitor cells and to understand its meaning for the control of stem cell functions.
